Comparison and evaluation of volumetric modulated arc therapy and intensity modulated radiation therapy plans for postoperative radiation therapy of prostate cancer patient using a rectal balloon

직장풍선을 삽입한 전립선암 환자의 수술 후 방사선 치료 시 용적변조와 세기변조방사선치료계획 비교 평가

  • Jung, hae youn (Department of Radiation Oncology, Seoul national university bundang hospital) ;
  • Seok, jin yong (Department of Radiation Oncology, Seoul national university bundang hospital) ;
  • Hong, joo wan (Department of Radiation Oncology, Seoul national university bundang hospital) ;
  • Chang, nam jun (Department of Radiation Oncology, Seoul national university bundang hospital) ;
  • Choi, byeong don (Department of Radiation Oncology, Seoul national university bundang hospital) ;
  • Park, jin hong (Department of Radiation Oncology, Seoul national university bundang hospital)
  • 정해윤 (분당서울대학교병원 방사선종양학과) ;
  • 석진용 (분당서울대학교병원 방사선종양학과) ;
  • 홍주완 (분당서울대학교병원 방사선종양학과) ;
  • 장남준 (분당서울대학교병원 방사선종양학과) ;
  • 최병돈 (분당서울대학교병원 방사선종양학과) ;
  • 박진홍 (분당서울대학교병원 방사선종양학과)
  • Received : 2015.05.29
  • Accepted : 2015.06.24
  • Published : 2015.06.30

Abstract

Purpose : The dose distribution of organ at risk (OAR) and normal tissue is affected by treatment technique in postoperative radiation therapy for prostate cancer. The aim of this study was to compare dose distribution characteristic and to evaluate treatment efficiency by devising VMAT plans according to applying differed number of arc and IMRT plan for postoperative patient of prostate cancer radiation therapy using a rectal balloon. Materials and Methods : Ten patients who received postoperative prostate radiation therapy in our hospital were compared. CT images of patients who inserted rectal balloon were acquired with 3 mm thickness and 10 MV energy of HD120MLC equipped Truebeam STx (Varian, Palo Alto, USA) was applied by using Eclipse (Version 11.0, Varian, Palo Alto, USA). 1 Arc, 2 Arc VMAT plans and 7-field IMRT plan were devised for each patient and same values were applied for dose volume constraint and plan normalization. To evaluate these plans, PTV coverage, conformity index (CI) and homogeneity index (HI) were compared and $R_{50%}$ was calculated to assess low dose spillage as per treatment plan. $D_{25%}$ of rectum and bladder Dmean were compared on OAR. And to evaluate the treatment efficiency, total monitor units(MU) and delivery time were considered. Each assessed result was analyzed by average value of 10 patients. Additionally, portal dosimetry was carried out for accuracy verification of beam delivery. Results : There was no significant difference on PTV coverage and HI among 3 plans. Especially CI and $R_{50%}$ on 7F-IMRT were the highest as 1.230, 3.991 respectively(p=0.00). Rectum $D_{25%}$ was similar between 1A-VMAT and 2A-VMAT. But approximately 7% higher value was observed on 7F-IMRT compare to the others(p=0.02) and bladder Dmean were similar among the all plan(P>0.05). Total MU were 494.7, 479.7, 757.9 respectively(P=0.00) for 1A-VMAT, 2A-VMAT, 7F-IMRT and at the most on 7F-IMRT. The delivery time were 65.2sec, 133.1sec, 145.5sec respectively(p=0.00). The obvious shortest time was observed on 1A-VMAT. All plans indicated over 99.5%(p=0.00) of gamma pass rate (2 mm, 2%) in portal dosimetry quality assurance. Conclusion : As a result of study, postoperative prostate cancer radiation therapy for patient using a rectal balloon, there was no significant difference of PTV coverage but 1A-VMAT and 2A-VMAT were more efficient for dose reduction of normal tissue and OARs. Between VMAT plans. $R_{50%}$ and MU were little lower in 2A-VMAT but 1A-VMAT has the shortest delivery time. So it is regarded to be an effective plan and it can reduce intra-fractional motion of patient also.

목 적 : 전립선암의 방사선치료는 치료기법에 따라 주요장기와 정상조직의 선량분포에 차이가 나타난다. 본 연구에서는 전립선암 환자의 수술 후 방사선치료 시 직장풍선을 삽입한 환자에게 회전수를 달리한 용적변조회전치료(volumetric modulated arc therapy, VMAT)계획과 세기변조방사선치료(intensity modulated radiation therapy, IMRT)계획을 각각 수립하여 선량분포 특성을 비교하고 치료의 효율성을 평가하고자 한다. 대상 및 방법 : 본원에서 전립선암 수술 후 방사선 치료를 시행한 10명의 환자를 대상으로 하였다. 직장풍선을 삽입한 환자의 CT영상을 3 mm 두께로 획득하고 Eclipse (Ver 11.0, Varian, Palo Alto, USA)를 사용하여 HD120MLC가 장착된 Truebeam STx (Varian, Palo Alto, USA)의 10 MV 에너지를 적용하였다. 환자마다 1 Arc, 2 Arc VMAT계획과 7조사면의 IMRT계획을 수립하였으며 각 치료계획의 선량체적제한과 plan normalization 값은 동일하게 적용하였다. 수립된 세 가지 치료계획을 평가하기위해 PTV의 coverage, conformity index (CI), homogeneity index (HI)를 비교하였고, PTV주변 정상조직의 선량퍼짐정도를 알아보기 위해 50% 등선량체적과 PTV체적의 비($R_{50%}$)를 산출하였다. 결정장기 (organ at risk, OAR)에서는 직장의 $D_{25%}$와 방광의 $D_{mean}$을 비교하였고 치료의 효율성을 평가하기 위해서 총 MU와 조사시간을 측정하였으며, 각 평가항목별 결과는 환자 10명의 평균값으로 비교분석하였다. 추가적으로 선량전달 정확도를 검증하기 위해 EPID를 이용한 portal dosimetry를 진행하였다. 결 과 : 각 치료계획에서 나타난 PTV coverage와 HI의 차이는 크지 않았지만 CI는 1A-VMAT, 2A-VMAT, 7F-IMRT에서 각각 1.036, 1.035, 1.230으로 VMAT에 비해 7F-IMRT가 높았고(p=0.00), $R_{50%}$는 3.083, 3.054, 3.991로 2A-VMAT이 제일 낮았고 7F-IMRT에서 가장 높게 나타났다(p=0.00). 치료계획에 따른 직장의 $D_{25%}$는 VMAT에서 비슷했지만 7F-IMRT가 약 7% 높게 나타났고(p=0.02), 방광의 $D_{mean}$은 큰 차이가 없었다(P>0.05). 총 MU는 1A-VMAT, 2A-VMAT, 7F-IMRT에서 각각 494.7, 479.7, 757.9로 7F-IMRT가 가장 많았고(p=0.00), 조사시간은 65.2초, 133.1초, 145.5초로 1A-VMAT이 확연히 짧았다(p=0.00). portal dosimetry 검증에서는 모든 치료계획에서 99.5% 이상의 gamma pass rate(2 mm, 2%)을 보였다(P=0.00). 결 론 : 본 연구결과 직장풍선을 삽입한 전립선암 환자의 수술 후 방사선치료 시, 치료기법에 따른 PTV coverage의 차이는 크지 않았지만 1A, 2A-VMAT이 7F-IMRT에 비해 정상조직과 직장선량을 낮추는데 효과적이었다. VMAT중에서는 $R_{50%}$와 MU가 2A-VMAT에서 다소 낮았지만 조사시간이 짧은 1A-VMAT이 치료에 더 효율적이며 환자의 치료 중 움직임 또한 줄일 수 있을 것으로 사료된다.

Keywords

References

  1. Thompson IM, Tangen CM, Paradelo J, et al : Adjuvant radiotherapy for pathological T3N0M0 prostate cancer significantly reduces risk of metastases and improves survival : long-term followup of a randomized clinical trial. J Urol. 2009;181:956-962 https://doi.org/10.1016/j.juro.2008.11.032
  2. Thompson IM, Tangen CM, Paradelo J, et al : Adjuvant radiotherapy for pathologically advanced prostate cancer: a randomized clinical trial. JAMA 2006;296:2329-2335 https://doi.org/10.1001/jama.296.19.2329
  3. Swanson GP, Goldman B, Tangen CM, et al : The prognostic impact of seminal vesicle involvement found at prostatectomy and the effects of adjuvant radiation: data from Southwest Oncology Froup 8794. J Urol. 2008;180:2453-2457; discussion 2458. https://doi.org/10.1016/j.juro.2008.08.037
  4. Michael J Zelefsky, Steven A Leibel, Paul B Gaudin. et al : Dose escalation with three-dimensional conformal radiation therapy affects the outcome in prostate caner. Int J Radiat Oncol Biol Phys. 1998;41(3):491-500 https://doi.org/10.1016/S0360-3016(98)00091-1
  5. Intensity Modulated Radiation Therapy Collaborative Working Gruop : Intensity modulated radiotherapy : Current status and issues of interest. Int J Radiat Oncol Biol Phys. 2001;51:880-917 https://doi.org/10.1016/S0360-3016(01)01749-7
  6. Ling CC, Burma C, Cui CS, et al : Conformal radiation treatment of prostate cancer using inversely-planned intensity-modulated photon beams produced with dynamic multileaf collimation. Int J Radiat Oncol Biol Phys. 1996;32:721-730
  7. 안용찬 : 세기조절 방사선치료 기술의 소개. J korean Med Assoc. 2011;54:1172-1178 https://doi.org/10.5124/jkma.2011.54.11.1172
  8. Hall EJ : Intensity-modulated arc therapy, protons, and the risk of second cancers. Int J Radiat Oncol Biol Phys. 2006;65:1-7 https://doi.org/10.1016/j.ijrobp.2006.01.027
  9. 박혜진, 김미화, 전미선 외 2인 : 아주대학교병원에서의 전립선암에 대한 래피드 아크 치료. 의학물리. 2010;2:183-191
  10. A. Fogliata, A. Clivio et al : Intensity modulation with photons for benign intracranial tumours: A planning comparison of volumetric single arc, helical arc and fixed gantry techniques. Radiother Oncol. 2009;89:254-262
  11. T-F. Lee, H-M. Ting et al : Dual Arc Volumetricmodulated Arc Radiotherapy(VMAT) of Nasopharyngeal Carcinomas: A Simultaneous Intergrated Boost Treatment Plan Comparison with Intensity-modulated Radiotherapies and Single Arc VMAT. Clinical Oncology. 2012;24:196-207 https://doi.org/10.1016/j.clon.2011.06.006
  12. D. Palma, E. Vollans, et al : Volumetric Modulated Arc Therapy for delivery of prostate Radiotherapy: Comparison with Intensity-Modulated Radiotherapy and Three-Dimensional Conformal Radiotherapy. Int J Radiat Oncol Biol Phys. 2008;72:996-1001 https://doi.org/10.1016/j.ijrobp.2008.02.047
  13. S. Yoo, Q. Jackie Wu, et al : Radiotherapy Treatmens plans with Rapidarc for prostate cancer involving seminal vesicles and lymph nodes. Int J Radiat Oncol Biol Phys. 2010;76:935-942 https://doi.org/10.1016/j.ijrobp.2009.07.1677
  14. Dirk Wolff, Florian Stieler, Grit Welzel et al : Volumetric modulated arc therapy(VMAT) vs. serial tomotherapy, step-and-shoot IMRT and 3D-conformal RT for treatment of prostate cancer. Radiother Oncol. 2009;93:226-233 https://doi.org/10.1016/j.radonc.2009.08.011
  15. Matthias Guckenberger, Anne Richter, Thomas Krieger et al : Is a single arc sufficient in volumetricmodulated arc therapy (VMAT) for xomplex-shaped target volumes?. Radiother Oncol. 2009;93:259-265 https://doi.org/10.1016/j.radonc.2009.08.015
  16. Yaoqin Xie, David Djajaputra, Chrostopher R. King et al : Intrafractional motion of the prostate during hypofractionated radiotherapy. Int J Radiat Oncol Biol Phys. 2008;72:236-246 https://doi.org/10.1016/j.ijrobp.2008.04.051
  17. Stephen F. Kry, Mohammad Salehpour, David S. Followill et al : The calculated risk of fatal secondary malignancies from intensity-modulated radiation therapy. Int J Radiat Oncol Biol Phys. 2005;62:1195-1203 https://doi.org/10.1016/j.ijrobp.2005.03.053
  18. Nicholas Hardcastle, Wolfgang A. Tome, Kerwin Foo et al : Comparison of prostate imrt and vmat biologically optimised treatment plans. Medical Dosimetry. 2010;36:292-298